Evidence reviews - March 2026
The following documents contain the evidence that was used to develop the 2026 recommendations:
- Ovarian reserve testing
- Subclinical hypothyroidism
- Screening hysteroscopy
- Endometrial receptivity testing
- Ovulation induction strategies for hypogonadotropic hypogonadism
- Cabergoline for hyperprolactinaemia
- Tubal surgery
- Surgery for hydrosalpinges before IVF
- Tubal catheterisation
- Fertility prediction models and IVF access
- Assisted reproduction techniques for people with unexplained fertility problems, mild endometriosis, and mild male factor fertility problems
- Intracytoplasmic sperm injection for non-male factor fertility problems
- Advanced sperm selection techniques as a fertility treatment add-on
- Pre-implantation genetic testing for aneuploidy as a fertility treatment add-on
- Embryo selection guided by continuous time-lapse sequence as a treatment add-on
- Endometrial scratch as a treatment add-on
- Immune therapies as a treatment add-on
- Fertility preservation
- Sperm DNA fragmentation
- Y chromosome microdeletion
- Hormone treatment for male factor fertility problems
- Treatments for ejaculatory failure
- Surgical interventions for obstructive azoospermia
- Treatments for varicocele
- Surgical sperm retrieval techniques
Other supporting evidence
Full guideline
This page was last updated: